127 related articles for article (PubMed ID: 3293056)
1. Altered interleukin production during Friend leukemia virus infection.
Lopez-Cepero M; Specter S; Matteucci D; Friedman H; Bendinelli M
Proc Soc Exp Biol Med; 1988 Jul; 188(3):353-63. PubMed ID: 3293056
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte surface receptors and leukemia virus-induced immunosuppression.
Friedman H; Kateley JR
Am J Clin Pathol; 1975 May; 63(5):735-47. PubMed ID: 1093386
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes.
Pettey CL; Collins JJ
Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757
[TBL] [Abstract][Full Text] [Related]
4. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
5. Use of silica to identify host mechanisms involved in suppression of established Friend virus leukemia.
Wirth JJ; Levy MH; Wheelock EF
J Immunol; 1976 Dec; 117(6):2124-30. PubMed ID: 186537
[TBL] [Abstract][Full Text] [Related]
6. Role of antibody response helper factors in immunosuppressive effects of friend leukemia virus.
Butler RC; Frier JM; Chapekar MS; Graham MO; Friedman H
Infect Immun; 1983 Mar; 39(3):1260-4. PubMed ID: 6220970
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
Kitagawa M; Kamisaku H; Aizawa S; Sado T
Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia.
Kitagawa M; Matsubara O; Kasuga T
Cancer Res; 1986 Jun; 46(6):3034-9. PubMed ID: 2870802
[TBL] [Abstract][Full Text] [Related]
9. Interleukins 1 and 2 production and responsiveness in the early stages of retroviral infections of mice.
Matteucci D; Giangregorio AM; Lopez-Cepero M; Specter S; Bendinelli M; Friedman H
Cell Immunol; 1989 Apr; 120(1):10-20. PubMed ID: 2539265
[TBL] [Abstract][Full Text] [Related]
10. Interactions of murine leukemia virus (MuLV) with isolated lymphocytes. II. Infections of B and T cells with Friend virus complex indiffusion chambers and in vitro: effect of polyclonal mitogens.
Cerny J; Hensgen PA; Fistel SH; Demler LM
Int J Cancer; 1976 Aug; 18(2):189-96. PubMed ID: 1085288
[TBL] [Abstract][Full Text] [Related]
11. Modulation of ex vivo cytokine production by splenocytes using in vitro combined therapeutics in murine retroviral model.
Kang LC; Kerben MJ; Ugen KE; Specter SC
DNA Cell Biol; 1999 Jul; 18(7):585-92. PubMed ID: 10433557
[TBL] [Abstract][Full Text] [Related]
12. Exogenous interleukin-2 abrogates differences in the proliferative responses to T cell mitogens among inbred strains of mice.
Lipoldová M; Zajícová A; Stĕdra J; Holán V
Cell Immunol; 1992 Jun; 142(1):177-85. PubMed ID: 1586954
[TBL] [Abstract][Full Text] [Related]
13. B and T lymphocyte activation by murine leukemia virus infection.
Bendinelli M; Friedman H
Adv Exp Med Biol; 1979; 121B():91-7. PubMed ID: 317564
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of erythroid precursors in mice infected with the anemic or the polycythemic strain of Friend leukemia virus.
Peschle C; Migliaccio G; Lettieri F; Migliaccio AR; Ceccarelli R; Barba P; Titti F; Rossi GB
Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2054-8. PubMed ID: 6929538
[TBL] [Abstract][Full Text] [Related]
15. Friend leukemia virus-induced leukemogenesis in fully H-2 incompatible C57BL/6-->C3H radiation bone marrow chimeras.
Kitagawa M; Kamisaku H; Sado T; Kasuga T
Leukemia; 1993 Jul; 7(7):1041-6. PubMed ID: 8321019
[TBL] [Abstract][Full Text] [Related]
16. Role of lymphoid cells in age-related change of susceptibility to Friend leukemia virus-induced leukemia.
Yamaguchi S; Kitagawa M; Inoue M; Tejima Y; Kimura M; Aizawa S; Utsuyama M; Hirokawa K
Mech Ageing Dev; 2001 Feb; 122(2):219-32. PubMed ID: 11166360
[TBL] [Abstract][Full Text] [Related]
17. The role of interferon-gamma in antiretroviral activity of methionine enkephalin and AZT in a murine cell culture.
Sin JI; Specter S
J Pharmacol Exp Ther; 1996 Dec; 279(3):1268-73. PubMed ID: 8968350
[TBL] [Abstract][Full Text] [Related]
18. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
Genovesi EV; Pettey CL; Collins JJ
Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
[TBL] [Abstract][Full Text] [Related]
19. Effects of Friend leukemia virus (FLV) inoculation in F1 mice and differentiation of FLV-induced leukemia.
Kitagawa M; Matsubara O; Kasuga T
Histol Histopathol; 1986 Oct; 1(4):335-40. PubMed ID: 2980128
[TBL] [Abstract][Full Text] [Related]
20. Induction of interleukin-3 by interleukin-1 in the absence of other exogenous stimuli.
Cavaillon JM; Vidard L; Boudaly S; Fitting C; Cohen L; Seman M; David B
Cell Immunol; 1990 Aug; 129(1):176-88. PubMed ID: 2364439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
